ALLK - Naked Brand Allakos Adagio Therapeutics among premarket losers' pack
Allakos (NASDAQ:ALLK) -86% after reports data from late-stage eosinophilic gastrointestinal disease studies. CalAmp (NASDAQ:CAMP) -21% on Q3 earnings release. Naked Brand Group (NASDAQ:NAKD) -14%. Adagio Therapeutics (NASDAQ:ADGI) -9%. Datasea (NASDAQ:DTSS) -9%. Creatd (NASDAQ:CRTD) -8%. Spruce Biosciences (NASDAQ:SPRB) -7%. Titan Pharmaceuticals (NASDAQ:TTNP) -7%. Quoin Pharmaceuticals (NASDAQ:QNRX) -7%. PAVmed (NASDAQ:PAVM) -6%. Advanced Human Imaging (NASDAQ:AHI) -5%. iSpecimen (NASDAQ:ISPC) -5%.
For further details see:
Naked Brand, Allakos, Adagio Therapeutics among premarket losers' pack